Billionaire Boys Club Member Forum (BBCMF)

[Ecomike]

Huge news on $NDTP , website updated with the team list and credentials / resumes jusy arrived:

http://www.NDTPharma.com

Click the menu top side for the TEAM page

Co-funder and co-founder and still a managing director of the Nasdaq multi billion dollar Carlyl Group that manages over 200 Billion dollars in Funds, who owns 24% of the private biotech that R/M with MILV to form NDTP is now confirmed as a team member.

Note worthy that he has been a director of the UPenn Trust fund that controls the UPennMed patents, must be over 25,000 of the patents.... and a 24% owner of previously CCA, LLC private since 2013 firm that R/M with MILV to form NDTP

"Edward J. Mathias

Edward J. Mathias is a senior Managing Director of The Carlyle Group and a member of Carlyle's Board of Directors. Mr. Mathias serves as an advisor to senior Management and is a member of the investment committees for Carlyle Growth, Asian Growth, European Technology, Middle East Northern Africa, Mexico Buyout and Sub-Saharan Africa funds."

And a new face:

https://www.unh.edu/unhtoday/2019/10/dr-mark-kester-present-part-cibbrmcbs-seminar-series

"Dr. Mark Kester

Dr. Mark Kester is a Professor of Pharmacology and the Director of the NanoSTAR Institute of the University of Virginia. Marks plays an integral role as Scientific Advisor to the company. He was previously the G. Thomas Passananti Professor of Pharmacology at Penn State Hershey College of Medicine and the inaugural Director of the Penn State Center for NanoMedicine and Materials.

Dr. Kester’s research interests include the design, characterization and validation of nanotechnologies for targeted drug delivery.

His laboratory has evaluated nanoliposomes, nanodendrimers and nanocolloids as effective drug delivery vehicles for pharmacological and molecular agents.

Recent work focuses on nontoxic nanoscale systemic delivery systems for hydrophobic pro-apoptotic lipids as well as siRNAs that target mutated tumorigenic proteins.

Dr. Kester has consulted with, or founded, several companies that have the license to his nano”Solutions”.

In addition, Dr. Kester is a co-author of Integrated Pharmacology, published by Elsevier, Ltd., which was recognized as a "highly commended textbook" by the British Medical Society."